Product Information
SUBVENITE 150 MG TABLET is a generic product labeled by OWP Pharmaceuticals, Inc., priced at $0.0728 per EA under NDC 69102015006. Its NADAC has been published 410 times since Aug 22, 2018.
The High Outlier badge above means this manufacturer's average price in the LAMOTRIGINE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
150 mg/1
Manufacturer
OWP Pharmaceuticals, Inc.NDC
69102015006
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LAMOTRIGINEApproval Type
Generic (ANDA)
FDA Application
ANDA078947On Market Since
3/10/2018
Pharmacological Classes
Price Statistics
The NADAC for SUBVENITE 150 MG TABLET has been published 410 times since Aug 22, 2018, and over the history we have for it it has risen 9.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0728 per EA |
|---|---|
| All-time high | $0.0921 (Jun 15, 2022) |
| All-time low | $0.0540 (Nov 20, 2024) |
| 52-week high | $0.0728 |
| 52-week low | $0.0630 |
| Median price | $0.0711 |
| Average price | $0.0720 |
| Largest weekly change | +25.4% (Aug 21, 2024) |
| Weeks tracked | 410 |
| Tracking since | Aug 22, 2018 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SUBVENITE 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SUBVENITE 150 MG TABLET, manufactured by OWP Pharmaceuticals, Inc., is $0.0728 per EA (NDC 69102015006), effective Jun 24, 2026.
How has the price of SUBVENITE 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for SUBVENITE 150 MG TABLET has risen 9.5%. It has been tracked across 410 weekly CMS publications since Aug 22, 2018.
What are the highest and lowest recorded NADAC prices for SUBVENITE 150 MG TABLET?
Since Aug 22, 2018, the NADAC for SUBVENITE 150 MG TABLET has ranged from a low of $0.0540 (Nov 20, 2024) to a high of $0.0921 (Jun 15, 2022), with a median of $0.0711 per EA.
Are there cheaper alternatives to SUBVENITE 150 MG TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, LAMOTRIGINE 150 MG TABLET, is $0.0625 per EA — about 14% below SUBVENITE 150 MG TABLET.
Who manufactures SUBVENITE 150 MG TABLET?
SUBVENITE 150 MG TABLET (NDC 69102015006) is labeled by OWP Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification